• Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

What’s New in Femtech This Week? (May 5, 2022)

By Femtech Insider News, Newsletter May 5, 2022
ShareTwitterFacebookPinterest-circled
  • Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

To continue reading…

Become a premium member and get unlimited access to articles, weekly analysis, free access to out webinars and more:

Subscribe

Already a subscriber? Log in here.

You May Also Like

Chronic Conditions, Hormonal Health, Investment, News October 18, 2023
Allara Raises $10M in Series A Funding to Address Care Gap for Women with Chronic Hormonal Conditions
Maternal Health, Menopause, News October 24, 2025
Progyny Expands Global Benefits Program to Include Pregnancy, Postpartum, and Menopause
Recent Posts
  • FDA Approves ENHERTU for Early Breast Cancer in Two New Indications
  • Why Investors Are Betting Big on Incontinence
  • Australian Medtech NinaMED Launches with $13.75M to Develop Non-Invasive Wearable for Overactive Bladder
  • Inside SPRIND’s Push to Build a Continuous Hormone Monitoring Industry in Europe
  • BlueWind Medical Raises $47.8M to Commercialize Implantable Neuromodulation Device for Urgency Urinary Incontinence

About Femtech Insider

Advertise with us!

Become a Member!

Contact us

Privacy Policy // Terms of Use

Femtech Insider Ltd. © 2026. All rights reserved.